nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—CYP3A4—Temozolomide—malignant glioma	0.0246	1	CbGbCtD
Mifepristone—Vaginal haemorrhage—Temozolomide—malignant glioma	0.013	0.0348	CcSEcCtD
Mifepristone—Hot flush—Temozolomide—malignant glioma	0.00749	0.02	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00743	0.0198	CcSEcCtD
Mifepristone—Menopausal symptoms—Temozolomide—malignant glioma	0.00743	0.0198	CcSEcCtD
Mifepristone—Thirst—Temozolomide—malignant glioma	0.00736	0.0197	CcSEcCtD
Mifepristone—Hypokalaemia—Carmustine—malignant glioma	0.0066	0.0176	CcSEcCtD
Mifepristone—Muscular weakness—Carmustine—malignant glioma	0.0064	0.0171	CcSEcCtD
Mifepristone—Hypokalaemia—Temozolomide—malignant glioma	0.00638	0.017	CcSEcCtD
Mifepristone—Breast disorder—Temozolomide—malignant glioma	0.00633	0.0169	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00631	0.0168	CcSEcCtD
Mifepristone—Muscular weakness—Temozolomide—malignant glioma	0.00618	0.0165	CcSEcCtD
Mifepristone—Infestation NOS—Temozolomide—malignant glioma	0.0054	0.0144	CcSEcCtD
Mifepristone—Infestation—Temozolomide—malignant glioma	0.0054	0.0144	CcSEcCtD
Mifepristone—Sinusitis—Temozolomide—malignant glioma	0.00507	0.0135	CcSEcCtD
Mifepristone—Haemoglobin—Carmustine—malignant glioma	0.00504	0.0135	CcSEcCtD
Mifepristone—Haemorrhage—Carmustine—malignant glioma	0.00502	0.0134	CcSEcCtD
Mifepristone—Oedema peripheral—Carmustine—malignant glioma	0.00494	0.0132	CcSEcCtD
Mifepristone—Connective tissue disorder—Carmustine—malignant glioma	0.00493	0.0132	CcSEcCtD
Mifepristone—Haemoglobin—Temozolomide—malignant glioma	0.00487	0.013	CcSEcCtD
Mifepristone—Haemorrhage—Temozolomide—malignant glioma	0.00485	0.0129	CcSEcCtD
Mifepristone—Oedema peripheral—Temozolomide—malignant glioma	0.00478	0.0127	CcSEcCtD
Mifepristone—Connective tissue disorder—Temozolomide—malignant glioma	0.00476	0.0127	CcSEcCtD
Mifepristone—Angiopathy—Temozolomide—malignant glioma	0.0044	0.0117	CcSEcCtD
Mifepristone—Mental disorder—Carmustine—malignant glioma	0.00439	0.0117	CcSEcCtD
Mifepristone—Mediastinal disorder—Temozolomide—malignant glioma	0.00437	0.0117	CcSEcCtD
Mifepristone—Malnutrition—Carmustine—malignant glioma	0.00437	0.0117	CcSEcCtD
Mifepristone—Chills—Temozolomide—malignant glioma	0.00435	0.0116	CcSEcCtD
Mifepristone—Mental disorder—Temozolomide—malignant glioma	0.00425	0.0113	CcSEcCtD
Mifepristone—Back pain—Carmustine—malignant glioma	0.00422	0.0113	CcSEcCtD
Mifepristone—Malnutrition—Temozolomide—malignant glioma	0.00422	0.0113	CcSEcCtD
Mifepristone—Back pain—Temozolomide—malignant glioma	0.00408	0.0109	CcSEcCtD
Mifepristone—Ill-defined disorder—Temozolomide—malignant glioma	0.00392	0.0104	CcSEcCtD
Mifepristone—Angioedema—Temozolomide—malignant glioma	0.00386	0.0103	CcSEcCtD
Mifepristone—Malaise—Temozolomide—malignant glioma	0.00381	0.0102	CcSEcCtD
Mifepristone—Hypertension—Carmustine—malignant glioma	0.00377	0.0101	CcSEcCtD
Mifepristone—Myalgia—Carmustine—malignant glioma	0.00372	0.00992	CcSEcCtD
Mifepristone—Anxiety—Carmustine—malignant glioma	0.0037	0.00989	CcSEcCtD
Mifepristone—Hypertension—Temozolomide—malignant glioma	0.00364	0.00972	CcSEcCtD
Mifepristone—Myalgia—Temozolomide—malignant glioma	0.00359	0.00959	CcSEcCtD
Mifepristone—Arthralgia—Temozolomide—malignant glioma	0.00359	0.00959	CcSEcCtD
Mifepristone—Anxiety—Temozolomide—malignant glioma	0.00358	0.00956	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00357	0.00952	CcSEcCtD
Mifepristone—Oedema—Carmustine—malignant glioma	0.00356	0.00951	CcSEcCtD
Mifepristone—Discomfort—Temozolomide—malignant glioma	0.00355	0.00947	CcSEcCtD
Mifepristone—Infection—Carmustine—malignant glioma	0.00354	0.00945	CcSEcCtD
Mifepristone—Dry mouth—Temozolomide—malignant glioma	0.00351	0.00938	CcSEcCtD
Mifepristone—Oedema—Temozolomide—malignant glioma	0.00344	0.00919	CcSEcCtD
Mifepristone—Infection—Temozolomide—malignant glioma	0.00342	0.00913	CcSEcCtD
Mifepristone—Anorexia—Carmustine—malignant glioma	0.0034	0.00907	CcSEcCtD
Mifepristone—Nervous system disorder—Temozolomide—malignant glioma	0.00338	0.00901	CcSEcCtD
Mifepristone—Skin disorder—Temozolomide—malignant glioma	0.00335	0.00893	CcSEcCtD
Mifepristone—Hypotension—Carmustine—malignant glioma	0.00333	0.00889	CcSEcCtD
Mifepristone—Anorexia—Temozolomide—malignant glioma	0.00328	0.00876	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00325	0.00867	CcSEcCtD
Mifepristone—Insomnia—Carmustine—malignant glioma	0.00322	0.0086	CcSEcCtD
Mifepristone—Dyspnoea—Carmustine—malignant glioma	0.00318	0.00848	CcSEcCtD
Mifepristone—Somnolence—Carmustine—malignant glioma	0.00317	0.00846	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00314	0.00837	CcSEcCtD
Mifepristone—Insomnia—Temozolomide—malignant glioma	0.00311	0.00831	CcSEcCtD
Mifepristone—Decreased appetite—Carmustine—malignant glioma	0.0031	0.00827	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Carmustine—malignant glioma	0.00308	0.00821	CcSEcCtD
Mifepristone—Dyspnoea—Temozolomide—malignant glioma	0.00307	0.00819	CcSEcCtD
Mifepristone—Somnolence—Temozolomide—malignant glioma	0.00306	0.00817	CcSEcCtD
Mifepristone—Constipation—Carmustine—malignant glioma	0.00305	0.00813	CcSEcCtD
Mifepristone—Pain—Carmustine—malignant glioma	0.00305	0.00813	CcSEcCtD
Mifepristone—Decreased appetite—Temozolomide—malignant glioma	0.00299	0.00799	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00297	0.00794	CcSEcCtD
Mifepristone—Fatigue—Temozolomide—malignant glioma	0.00297	0.00792	CcSEcCtD
Mifepristone—Pain—Temozolomide—malignant glioma	0.00295	0.00786	CcSEcCtD
Mifepristone—Constipation—Temozolomide—malignant glioma	0.00295	0.00786	CcSEcCtD
Mifepristone—Feeling abnormal—Carmustine—malignant glioma	0.00294	0.00784	CcSEcCtD
Mifepristone—Gastrointestinal pain—Carmustine—malignant glioma	0.00291	0.00778	CcSEcCtD
Mifepristone—Feeling abnormal—Temozolomide—malignant glioma	0.00284	0.00757	CcSEcCtD
Mifepristone—Abdominal pain—Carmustine—malignant glioma	0.00282	0.00752	CcSEcCtD
Mifepristone—Body temperature increased—Carmustine—malignant glioma	0.00282	0.00752	CcSEcCtD
Mifepristone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00282	0.00752	CcSEcCtD
Mifepristone—Urticaria—Temozolomide—malignant glioma	0.00274	0.0073	CcSEcCtD
Mifepristone—Abdominal pain—Temozolomide—malignant glioma	0.00272	0.00727	CcSEcCtD
Mifepristone—Body temperature increased—Temozolomide—malignant glioma	0.00272	0.00727	CcSEcCtD
Mifepristone—Hypersensitivity—Carmustine—malignant glioma	0.00263	0.00701	CcSEcCtD
Mifepristone—Asthenia—Carmustine—malignant glioma	0.00256	0.00682	CcSEcCtD
Mifepristone—Hypersensitivity—Temozolomide—malignant glioma	0.00254	0.00677	CcSEcCtD
Mifepristone—Asthenia—Temozolomide—malignant glioma	0.00247	0.00659	CcSEcCtD
Mifepristone—Diarrhoea—Carmustine—malignant glioma	0.00244	0.00651	CcSEcCtD
Mifepristone—Pruritus—Temozolomide—malignant glioma	0.00244	0.0065	CcSEcCtD
Mifepristone—Dizziness—Carmustine—malignant glioma	0.00236	0.00629	CcSEcCtD
Mifepristone—Diarrhoea—Temozolomide—malignant glioma	0.00236	0.00629	CcSEcCtD
Mifepristone—Dizziness—Temozolomide—malignant glioma	0.00228	0.00608	CcSEcCtD
Mifepristone—Vomiting—Carmustine—malignant glioma	0.00227	0.00605	CcSEcCtD
Mifepristone—Rash—Carmustine—malignant glioma	0.00225	0.006	CcSEcCtD
Mifepristone—Dermatitis—Carmustine—malignant glioma	0.00224	0.00599	CcSEcCtD
Mifepristone—Headache—Carmustine—malignant glioma	0.00223	0.00596	CcSEcCtD
Mifepristone—Vomiting—Temozolomide—malignant glioma	0.00219	0.00584	CcSEcCtD
Mifepristone—Rash—Temozolomide—malignant glioma	0.00217	0.0058	CcSEcCtD
Mifepristone—Dermatitis—Temozolomide—malignant glioma	0.00217	0.00579	CcSEcCtD
Mifepristone—Headache—Temozolomide—malignant glioma	0.00216	0.00576	CcSEcCtD
Mifepristone—Nausea—Carmustine—malignant glioma	0.00212	0.00565	CcSEcCtD
Mifepristone—Nausea—Temozolomide—malignant glioma	0.00205	0.00546	CcSEcCtD
Mifepristone—ABCC1—Disease—JAG1—malignant glioma	0.000215	0.000358	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000211	0.000352	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FBXW7—malignant glioma	0.000211	0.000351	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00021	0.000349	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CDKN2B—malignant glioma	0.000208	0.000346	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH2—malignant glioma	0.000206	0.000343	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTT1—malignant glioma	0.000206	0.000343	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.000204	0.00034	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KNG1—malignant glioma	0.000202	0.000336	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000199	0.000332	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—IDH2—malignant glioma	0.000197	0.000328	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NCOR1—malignant glioma	0.000197	0.000328	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NOTCH1—malignant glioma	0.000196	0.000327	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000196	0.000327	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ASMT—malignant glioma	0.000196	0.000327	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000196	0.000327	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000196	0.000326	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000194	0.000322	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS1—malignant glioma	0.000193	0.000322	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000192	0.00032	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NTRK1—malignant glioma	0.000192	0.00032	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000189	0.000315	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPARG—malignant glioma	0.000185	0.000309	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000185	0.000308	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ASMT—malignant glioma	0.000185	0.000308	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BCAN—malignant glioma	0.000185	0.000307	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000183	0.000305	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00018	0.0003	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTT1—malignant glioma	0.00018	0.000299	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—BCHE—malignant glioma	0.00018	0.000299	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP3—malignant glioma	0.000179	0.000298	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC5A5—malignant glioma	0.000177	0.000295	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN2B—malignant glioma	0.000177	0.000295	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000176	0.000293	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BCAN—malignant glioma	0.000174	0.000289	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTK2—malignant glioma	0.000172	0.000287	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000171	0.000285	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—IDH1—malignant glioma	0.000169	0.000282	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HES1—malignant glioma	0.000169	0.000282	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000168	0.00028	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NCOR1—malignant glioma	0.000168	0.00028	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000168	0.000279	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—malignant glioma	0.000167	0.000278	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000166	0.000277	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN2B—malignant glioma	0.000165	0.000275	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000165	0.000275	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000164	0.000273	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000163	0.000272	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PDGFRA—malignant glioma	0.000161	0.000268	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000161	0.000267	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HES1—malignant glioma	0.000158	0.000262	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000158	0.000262	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NCOR1—malignant glioma	0.000157	0.000261	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—BCHE—malignant glioma	0.000157	0.000261	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SPP1—malignant glioma	0.000156	0.00026	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000155	0.000258	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PDGFRA—malignant glioma	0.00015	0.00025	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH1—malignant glioma	0.00015	0.000249	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NCOR1—malignant glioma	0.00015	0.000249	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000149	0.000248	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—IDH2—malignant glioma	0.000149	0.000248	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TERT—malignant glioma	0.000148	0.000247	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000145	0.000241	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PDGFB—malignant glioma	0.000145	0.000241	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGFR1—malignant glioma	0.000144	0.00024	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTP1—malignant glioma	0.000143	0.000238	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—COX8A—malignant glioma	0.000142	0.000237	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HIF1A—malignant glioma	0.000142	0.000236	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—malignant glioma	0.000141	0.000235	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—IDH2—malignant glioma	0.00014	0.000233	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2B6—malignant glioma	0.00014	0.000233	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CAT—malignant glioma	0.000139	0.000231	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HLA-A—malignant glioma	0.000138	0.00023	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TERT—malignant glioma	0.000138	0.00023	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000137	0.000228	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CAV1—malignant glioma	0.000137	0.000228	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KDR—malignant glioma	0.000136	0.000226	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PDGFB—malignant glioma	0.000135	0.000224	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000134	0.000223	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGFR1—malignant glioma	0.000134	0.000223	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HIF1A—malignant glioma	0.000132	0.00022	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000132	0.000219	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NCOR1—malignant glioma	0.000131	0.000219	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—F2—malignant glioma	0.00013	0.000217	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FN1—malignant glioma	0.00013	0.000217	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTT1—malignant glioma	0.00013	0.000216	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BAD—malignant glioma	0.000129	0.000215	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—IDH1—malignant glioma	0.000128	0.000213	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000128	0.000213	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CAV1—malignant glioma	0.000128	0.000213	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH1—malignant glioma	0.000128	0.000213	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	0.000127	0.000211	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000127	0.000211	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD80—malignant glioma	0.000125	0.000208	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CG—malignant glioma	0.000125	0.000208	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APC—malignant glioma	0.000125	0.000208	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTP1—malignant glioma	0.000125	0.000207	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SPHK1—malignant glioma	0.000124	0.000206	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGF—malignant glioma	0.000123	0.000205	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTPN11—malignant glioma	0.000123	0.000204	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS1—malignant glioma	0.000122	0.000203	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CAT—malignant glioma	0.000121	0.000202	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000121	0.000202	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ASMT—malignant glioma	0.000121	0.000201	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—IDH1—malignant glioma	0.000121	0.000201	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BAD—malignant glioma	0.00012	0.0002	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOTCH1—malignant glioma	0.000119	0.000198	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BRAF—malignant glioma	0.000117	0.000195	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000117	0.000194	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD80—malignant glioma	0.000117	0.000194	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000116	0.000194	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—malignant glioma	0.000116	0.000194	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGF—malignant glioma	0.000115	0.000192	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NCOR1—malignant glioma	0.000115	0.000191	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTPN11—malignant glioma	0.000114	0.00019	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT2—malignant glioma	0.000114	0.00019	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000114	0.00019	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BCAN—malignant glioma	0.000114	0.000189	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH1—malignant glioma	0.000114	0.000189	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—BCHE—malignant glioma	0.000113	0.000188	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000113	0.000188	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC5A5—malignant glioma	0.000112	0.000186	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CD—malignant glioma	0.00011	0.000183	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BRAF—malignant glioma	0.000109	0.000182	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—malignant glioma	0.000107	0.000178	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CAV1—malignant glioma	0.000107	0.000178	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT2—malignant glioma	0.000107	0.000177	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—malignant glioma	0.000106	0.000176	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGF2—malignant glioma	0.000105	0.000175	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CD—malignant glioma	0.000102	0.00017	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000102	0.00017	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MDM2—malignant glioma	9.84e-05	0.000164	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—malignant glioma	9.81e-05	0.000163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RAF1—malignant glioma	9.8e-05	0.000163	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF2—malignant glioma	9.8e-05	0.000163	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—malignant glioma	9.75e-05	0.000162	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—malignant glioma	9.7e-05	0.000161	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CB—malignant glioma	9.57e-05	0.000159	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.52e-05	0.000158	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—malignant glioma	9.41e-05	0.000157	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CAV1—malignant glioma	9.33e-05	0.000155	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—malignant glioma	9.24e-05	0.000154	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—malignant glioma	9.2e-05	0.000153	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS1—malignant glioma	9.19e-05	0.000153	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MDM2—malignant glioma	9.17e-05	0.000153	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—IDH2—malignant glioma	9.16e-05	0.000153	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RAF1—malignant glioma	9.14e-05	0.000152	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—malignant glioma	9.04e-05	0.00015	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTP1—malignant glioma	9.01e-05	0.00015	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CB—malignant glioma	8.92e-05	0.000148	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—malignant glioma	8.84e-05	0.000147	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—malignant glioma	8.8e-05	0.000147	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—malignant glioma	8.79e-05	0.000146	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAT—malignant glioma	8.76e-05	0.000146	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS1—malignant glioma	8.66e-05	0.000144	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.62e-05	0.000143	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CD—malignant glioma	8.57e-05	0.000143	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BCHE—malignant glioma	8.54e-05	0.000142	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—malignant glioma	8.5e-05	0.000142	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A5—malignant glioma	8.44e-05	0.00014	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—malignant glioma	8.32e-05	0.000138	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NCOR1—malignant glioma	8.28e-05	0.000138	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—malignant glioma	8.27e-05	0.000138	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—malignant glioma	8.21e-05	0.000137	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—malignant glioma	8.05e-05	0.000134	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BCHE—malignant glioma	8.05e-05	0.000134	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A5—malignant glioma	7.95e-05	0.000132	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—IDH1—malignant glioma	7.88e-05	0.000131	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.77e-05	0.000129	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—malignant glioma	7.71e-05	0.000128	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SPHK1—malignant glioma	7.62e-05	0.000127	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CD—malignant glioma	7.47e-05	0.000124	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.47e-05	0.000124	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CB—malignant glioma	7.47e-05	0.000124	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—malignant glioma	7.47e-05	0.000124	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—malignant glioma	7.4e-05	0.000123	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—malignant glioma	7.4e-05	0.000123	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—malignant glioma	7.33e-05	0.000122	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—malignant glioma	6.89e-05	0.000115	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—malignant glioma	6.87e-05	0.000114	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTP1—malignant glioma	6.8e-05	0.000113	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAV1—malignant glioma	6.75e-05	0.000112	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—malignant glioma	6.72e-05	0.000112	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAT—malignant glioma	6.61e-05	0.00011	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CB—malignant glioma	6.51e-05	0.000108	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—malignant glioma	6.46e-05	0.000107	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—malignant glioma	6.45e-05	0.000107	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—malignant glioma	6.4e-05	0.000107	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTP1—malignant glioma	6.4e-05	0.000107	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—malignant glioma	6.35e-05	0.000106	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—malignant glioma	6.26e-05	0.000104	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NCOR1—malignant glioma	6.25e-05	0.000104	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAT—malignant glioma	6.23e-05	0.000104	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—malignant glioma	6.15e-05	0.000102	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—malignant glioma	6.11e-05	0.000102	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—malignant glioma	6.04e-05	0.000101	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—malignant glioma	5.93e-05	9.87e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—malignant glioma	5.92e-05	9.85e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NCOR1—malignant glioma	5.89e-05	9.8e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—malignant glioma	5.83e-05	9.71e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS1—malignant glioma	5.66e-05	9.42e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—malignant glioma	5.64e-05	9.39e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—malignant glioma	5.63e-05	9.37e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—malignant glioma	5.58e-05	9.3e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—malignant glioma	5.44e-05	9.05e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CD—malignant glioma	5.4e-05	8.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BCHE—malignant glioma	5.26e-05	8.76e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.2e-05	8.65e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAV1—malignant glioma	5.09e-05	8.48e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAV1—malignant glioma	4.8e-05	7.99e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—malignant glioma	4.77e-05	7.93e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CB—malignant glioma	4.71e-05	7.84e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—malignant glioma	4.67e-05	7.77e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—malignant glioma	4.64e-05	7.72e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—malignant glioma	4.55e-05	7.58e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—malignant glioma	4.48e-05	7.45e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—malignant glioma	4.44e-05	7.39e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.37e-05	7.28e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—malignant glioma	4.24e-05	7.05e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—malignant glioma	4.22e-05	7.02e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTP1—malignant glioma	4.19e-05	6.97e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CD—malignant glioma	4.08e-05	6.79e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAT—malignant glioma	4.07e-05	6.78e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—malignant glioma	4.07e-05	6.77e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—malignant glioma	3.97e-05	6.61e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOR1—malignant glioma	3.85e-05	6.41e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.84e-05	6.4e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—malignant glioma	3.72e-05	6.19e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CB—malignant glioma	3.55e-05	5.92e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—malignant glioma	3.52e-05	5.86e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.35e-05	5.57e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—malignant glioma	3.32e-05	5.52e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—malignant glioma	3.24e-05	5.4e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAV1—malignant glioma	3.14e-05	5.22e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—malignant glioma	3.07e-05	5.11e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—malignant glioma	2.89e-05	4.82e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.87e-05	4.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.86e-05	4.76e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—malignant glioma	2.76e-05	4.59e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.51e-05	4.18e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—malignant glioma	2.35e-05	3.9e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.19e-05	3.64e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—malignant glioma	2.17e-05	3.61e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—malignant glioma	2.17e-05	3.61e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.04e-05	3.4e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—malignant glioma	1.89e-05	3.15e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—malignant glioma	1.77e-05	2.95e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—malignant glioma	1.67e-05	2.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.33e-05	2.22e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—malignant glioma	1.09e-05	1.81e-05	CbGpPWpGaD
